Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.
- DOI
- 10.1016/s1470-2045(09)70330-4
- Published
- 2010 Jan
- Container
- The Lancet. Oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s1470-2045-09-70330-4,
title = {Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.},
author = {Folprecht G and Gruenberger T and Bechstein WO and Raab HR and Lordick F and Hartmann JT and Lang H and Frilling A and Stoehlmacher J and Weitz J and Konopke R and Stroszczynski C and Liersch T and Ockert D and Herrmann T and Goekkurt E and Parisi F and Köhne CH},
year = {2010},
journal = {The Lancet. Oncology},
doi = {10.1016/s1470-2045(09)70330-4},
url = {https://doi.org/10.1016/s1470-2045(09)70330-4}
}RIS
TY - JOUR TI - Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. AU - Folprecht G AU - Gruenberger T AU - Bechstein WO AU - Raab HR AU - Lordick F AU - Hartmann JT AU - Lang H AU - Frilling A AU - Stoehlmacher J AU - Weitz J AU - Konopke R AU - Stroszczynski C AU - Liersch T AU - Ockert D AU - Herrmann T AU - Goekkurt E AU - Parisi F AU - Köhne CH PY - 2010 JO - The Lancet. Oncology DO - 10.1016/s1470-2045(09)70330-4 UR - https://doi.org/10.1016/s1470-2045(09)70330-4 ER -
APA
G, F., T, G., WO, B., HR, R., F, L., JT, H., H, L., A, F., J, S., J, W., R, K., C, S., T, L., D, O., T, H., E, G., F, P., & CH, K. (2010). Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(09)70330-4
Source records
- pubmed · retrieved 2026-09-25T23:25:52.278Z